Back to Top Skip to main content Skip to sub-navigation

Tidewater set to become fifth Military Health System market

Military health personnel reading a medical machine Navy Lt. Cmdr. Elaine Medley (right), assigned to Naval Medical Center Portsmouth, instructs Army Maj. Joanna Bailey and Army 1st Lt. Kristin Salcedo, both assigned to McDonald Army Health Center, in a simulated training on how to administer respiratory care in preparation to support the USNS Comfort’s deployment in the fight against COVID-19. Naval Medical Center Portsmouth and McDonald Army Health Center will both be part of the DHA’s Tidewater Market (Photo by: Army Lt. Col. Brad Cunningham, McDonald Army Health Center).

Recommended Content:

MHS Toolkits and Branding Guidance | MHS Toolkits and Branding Guidance | Coronavirus | Military Health System Transformation

The Defense Health Agency officially established the Tidewater Market in southeast Virginia on April 19.  This is the fifth Military Health System market established to manage military medical treatment facilities as they transition to DHA.

Tidewater follows the National Capital Region, Central North Carolina, Jacksonville, and Coastal Mississippi markets, which were established in January 2020. It is the first transition since the COVID-19 national health emergency was declared.

A market is a group of MTFs in one geographic area working together with its TRICARE partners, Veterans Affairs hospitals, other federal health care organizations, private sector teaching hospitals and medical universities, as well as other health care partners. Markets operate as a system to support the sharing of patients, staff, budget, and other functions across facilities to improve readiness and the delivery and coordination of health services.

Although DOD decided early in the COVID-19 pandemic to pause transition, activities resumed in November, and a complete transition of management responsibilities for MTFs from the services to the DHA is scheduled to be completed by September 2021.

"The establishment of this market provides a true opportunity to optimize health care for our beneficiaries by focusing on outcomes and access across the Tidewater market," said Navy Rear Adm. Darin Via, Tidewater market manager. "It also allows us to work towards standardization of processes, creating an easier environment for our patients to navigate within.

Via said the ability of patients to schedule appointments across multiple facilities, and the ability of MTFs to appoint personnel and refer patients in order to meet specific demands are among the many advantages of a market model. He also said standardization of processes, policy, and monitoring efforts ultimately results in improved quality and safety.

Via foresees a smooth transition focused on mission readiness.

"Transition will have no immediate impact on patient care and will be seamless to beneficiaries," he said. "This transformation builds on our successes on the battlefield with an eye on emerging global challenges to ensure we are ready to fight tonight."

The Tidewater market includes the following military medical treatment facilities:

Navy

  • Naval Medical Center Portsmouth
  • Branch Health Clinic, Joint Expeditionary Base Little Creek (Boone Clinic)
  • BHC, Dam Neck Annex
  • BHC, Norfolk Naval Station (Sewells Point)
  • BHC, Norfolk Naval Shipyard
  • BHC, Chesapeake (Northwest Annex)
  • BHC, Naval Air Station Oceana
  • BHC, Yorktown (Naval Weapons Station)
  • TRICARE PrimeA managed care option available in Prime Service Areas in the United States; you have an assigned primary care manager who provides most of your care.TRICARE Prime Clinic Virginia Beach
  • TRICARE Prime Clinic Chesapeake
  • TRICARE Prime Clinic Suffolk

Army

  • McDonald Army Health Center, Fort Eustis
  • Troop Medical Clinic 1 (TMC1)
  • Troop Medical Clinic 2 (TMC2)
  • Fort Story Army Health Clinic
  • Community-Based Medical Home Williamsburg

Air Force

  • USAF Hospital Langley Air Force Base (633 MDG)

"Establishment of the Tidewater market is a big step forward for the Military Health System, and for our patients," said Dr. Barclay Butler, DHA's assistant director for Management.

Butler reiterated that the pandemic has served to highlight the benefit of a market model, which ultimately results in higher quality care for MTF recipients.

"The market construct lets military medical treatment facilities coordinate locally to share patients, staff, and resources to improve care, patient access, and readiness activities," said Butler. "The global COVID-19 pandemic demonstrates the value of the market construct, giving our MTFs expanded flexibility and capability to adjust to local conditions in response to a crisis, while giving MHS patients a standard, high-quality experience across the whole enterprise."

The complete transition of MTFs to the DHA includes 19 direct reporting markets within the U.S., 18 small markets and many stand-alone MTFs across the country that will report to a Small Market and Stand Alone Organization, and two overseas Defense Health Regions.

The Military Health System remains committed to the congressionally-directed goal of transitioning all MTFs to DHA authority, direction, and control by Sept. 30, 2021.

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

Continuing Implementation of the Reform of the Military Health System

Policy

This memorandum directs the continued implementation of the Military Health System (MHS) organizational reform required by 10 U.S.C. § 1073c, and sections 71 land 712 of the John S. McCain National Defense Authorization Act (NDAA) for Fiscal Year (FY) 2019. The DoD policy for this reform is guided by the goals of improved readiness, better health, better care, and lower cost. The Department will advance these objectives through specific organizational reforms directed by Congress and the continued direction of the Secretary of Defense·anct the National Defense Strategy.

Showing results 1 - 11 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.